| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 123,2 M € | -3.2% | 127,4 M € | +2.2% | 124,6 M € | +8.6% | 114,7 M € | -31.3% | 166,9 M € | -16.9% | 200,9 M € | +17.8% | 170,5 M € | +10.0% | 155,0 M € | -9.4% | 171,1 M € | +0.4% | 170,4 M € | +7.6% | 158,4 M € | +17.4% | 134,8 M € | -10.7% | 151,0 M € | |
| EBITDA | 2,7 M € | +4.0% | 2,6 M € | +13488.6% | 19,5 k € | -99.0% | 2,0 M € | -35.3% | 3,2 M € | -14.0% | 3,7 M € | +9.6% | 3,3 M € | +6.7% | 3,1 M € | -19.2% | 3,9 M € | +18.8% | 3,3 M € | +20.0% | 2,7 M € | +3.6% | 2,6 M € | -12.1% | 3,0 M € | |
| Operating profit | 2,6 M € | +2.5% | 2,5 M € | +3078.9% | -85,0 k € | -104.4% | 1,9 M € | -36.5% | 3,0 M € | -13.5% | 3,5 M € | +9.3% | 3,2 M € | +6.7% | 3,0 M € | -19.8% | 3,7 M € | +19.0% | 3,1 M € | +20.4% | 2,6 M € | +0.8% | 2,6 M € | -11.5% | 2,9 M € | |
| Profit/loss | 2,6 M € | +220.2% | 826,5 k € | +590.9% | 119,6 k € | -93.2% | 1,8 M € | +23.1% | 1,4 M € | -62.2% | 3,8 M € | +33.0% | 2,8 M € | -18.9% | 3,5 M € | +8.5% | 3,2 M € | -16.4% | 3,9 M € | +22.0% | 3,2 M € | -26.5% | 4,3 M € | +29.4% | 3,3 M € | |
| Equity | 52,4 M € | -0.7% | 52,7 M € | -4.0% | 54,9 M € | -5.0% | 57,8 M € | +3.1% | 56,0 M € | +2.6% | 54,6 M € | +7.5% | 50,8 M € | +5.9% | 48,0 M € | +7.9% | 44,4 M € | +7.9% | 41,2 M € | +10.4% | 37,3 M € | +9.3% | 34,2 M € | +14.5% | 29,8 M € | |
| Total assets | 96,0 M € | -25.1% | 128,1 M € | +38.4% | 92,6 M € | -12.3% | 105,6 M € | +9.3% | 96,6 M € | +0.4% | 96,2 M € | -7.2% | 103,6 M € | -3.2% | 107,1 M € | +16.8% | 91,7 M € | -13.0% | 105,4 M € | -3.4% | 109,1 M € | +34.3% | 81,3 M € | +1.9% | 79,7 M € | |
| Cash | 5,5 M € | -31.9% | 8,0 M € | +66.7% | 4,8 M € | +96.1% | 2,5 M € | +44.9% | 1,7 M € | -10.4% | 1,9 M € | +69.4% | 1,1 M € | -28.9% | 1,6 M € | -34.0% | 2,4 M € | +16.6% | 2,0 M € | +67.3% | 1,2 M € | +2.7% | 1,2 M € | -81.8% | 6,5 M € | |
| Debts | 43,5 M € | -42.2% | 75,3 M € | +100.3% | 37,6 M € | -21.3% | 47,7 M € | +17.9% | 40,5 M € | -2.5% | 41,5 M € | -21.3% | 52,8 M € | -10.7% | 59,1 M € | +25.1% | 47,2 M € | -26.4% | 64,2 M € | -10.6% | 71,8 M € | +52.4% | 47,1 M € | -5.5% | 49,8 M € | |
| Staff | 27,5 | 26 | 25,2 | 24,6 | 24,1 | 24,1 | 21,6 | 20,4 | 19,7 | 17,8 | 18,4 | 18,2 | 17,7 | |||||||||||||
Public limited company · Machelen (Brab.) · incorporated on 14/03/1996 · 27,5 ETP
Public limited company profitable and well capitalised. Cash position declining (-31.9%).
Solid counterparty for a standard engagement.
ISK BIOSCIENCES EUROPE is a Public limited company incorporated in 1996. Its main activity is: Manufacture of pesticides and other agrochemical products. Its registered office is in Machelen (Brab.). It employs on average 27,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette